nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—CYP1A1—head and neck cancer	0.346	1	CbGaD
Progesterone—ABCB11—Vinblastine—head and neck cancer	0.0667	0.145	CbGbCtD
Progesterone—CYP1B1—Docetaxel—head and neck cancer	0.055	0.119	CbGbCtD
Progesterone—ABCC1—Vinblastine—head and neck cancer	0.0474	0.103	CbGbCtD
Progesterone—SLC22A2—Vinblastine—head and neck cancer	0.043	0.0932	CbGbCtD
Progesterone—ABCC1—Docetaxel—head and neck cancer	0.0391	0.0848	CbGbCtD
Progesterone—CYP2A6—Fluorouracil—head and neck cancer	0.037	0.0802	CbGbCtD
Progesterone—CYP2D6—Hydroxyurea—head and neck cancer	0.0305	0.0661	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0193	0.0419	CbGbCtD
Progesterone—CYP3A7—Docetaxel—head and neck cancer	0.0193	0.0419	CbGbCtD
Progesterone—CYP2C8—Fluorouracil—head and neck cancer	0.0182	0.0396	CbGbCtD
Progesterone—CYP3A5—Docetaxel—head and neck cancer	0.0145	0.0314	CbGbCtD
Progesterone—CYP1A2—Fluorouracil—head and neck cancer	0.0141	0.0306	CbGbCtD
Progesterone—CYP2C9—Fluorouracil—head and neck cancer	0.0127	0.0276	CbGbCtD
Progesterone—ABCB1—Vinblastine—head and neck cancer	0.0114	0.0248	CbGbCtD
Progesterone—CYP2D6—Vinblastine—head and neck cancer	0.0108	0.0234	CbGbCtD
Progesterone—ABCB1—Docetaxel—head and neck cancer	0.00943	0.0205	CbGbCtD
Progesterone—AR—duct of salivary gland—head and neck cancer	0.00828	0.248	CbGeAlD
Progesterone—CYP3A4—Vinblastine—head and neck cancer	0.00685	0.0149	CbGbCtD
Progesterone—CYP3A4—Docetaxel—head and neck cancer	0.00565	0.0123	CbGbCtD
Progesterone—SLC22A3—tongue—head and neck cancer	0.000941	0.0281	CbGeAlD
Progesterone—Raised liver function tests—Docetaxel—head and neck cancer	0.000846	0.00956	CcSEcCtD
Progesterone—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.000795	0.00898	CcSEcCtD
Progesterone—Neoplasm—Vinblastine—head and neck cancer	0.000746	0.00842	CcSEcCtD
Progesterone—CYP1B1—hair follicle—head and neck cancer	0.000741	0.0222	CbGeAlD
Progesterone—Menstruation irregular—Docetaxel—head and neck cancer	0.000706	0.00797	CcSEcCtD
Progesterone—Foetor hepaticus—Docetaxel—head and neck cancer	0.000689	0.00778	CcSEcCtD
Progesterone—Neoplasm—Hydroxyurea—head and neck cancer	0.00068	0.00768	CcSEcCtD
Progesterone—ABCC1—hair follicle—head and neck cancer	0.000667	0.0199	CbGeAlD
Progesterone—SHBG—neck—head and neck cancer	0.000656	0.0196	CbGeAlD
Progesterone—SLC22A3—mouth—head and neck cancer	0.000633	0.0189	CbGeAlD
Progesterone—CYP17A1—connective tissue—head and neck cancer	0.000631	0.0189	CbGeAlD
Progesterone—Speech disorder—Fluorouracil—head and neck cancer	0.000629	0.00711	CcSEcCtD
Progesterone—Tenderness—Fluorouracil—head and neck cancer	0.00062	0.00701	CcSEcCtD
Progesterone—Disorientation—Hydroxyurea—head and neck cancer	0.00061	0.00689	CcSEcCtD
Progesterone—Embolism—Docetaxel—head and neck cancer	0.000609	0.00688	CcSEcCtD
Progesterone—Hepatic failure—Hydroxyurea—head and neck cancer	0.000608	0.00686	CcSEcCtD
Progesterone—Herpes simplex—Fluorouracil—head and neck cancer	0.000587	0.00664	CcSEcCtD
Progesterone—Redness—Docetaxel—head and neck cancer	0.000579	0.00654	CcSEcCtD
Progesterone—Liver disorder—Docetaxel—head and neck cancer	0.000573	0.00647	CcSEcCtD
Progesterone—Dysarthria—Fluorouracil—head and neck cancer	0.000572	0.00646	CcSEcCtD
Progesterone—Face oedema—Hydroxyurea—head and neck cancer	0.000527	0.00595	CcSEcCtD
Progesterone—Neuritis—Docetaxel—head and neck cancer	0.000523	0.00591	CcSEcCtD
Progesterone—NR3C2—parotid gland—head and neck cancer	0.000518	0.0155	CbGeAlD
Progesterone—Angina pectoris—Vinblastine—head and neck cancer	0.000504	0.00569	CcSEcCtD
Progesterone—NR3C2—saliva-secreting gland—head and neck cancer	0.000496	0.0148	CbGeAlD
Progesterone—Breast disorder—Hydroxyurea—head and neck cancer	0.000493	0.00557	CcSEcCtD
Progesterone—SHBG—connective tissue—head and neck cancer	0.00047	0.0141	CbGeAlD
Progesterone—ESR1—neck—head and neck cancer	0.000462	0.0138	CbGeAlD
Progesterone—Depression—Vinblastine—head and neck cancer	0.00046	0.0052	CcSEcCtD
Progesterone—NR3C2—connective tissue—head and neck cancer	0.000456	0.0136	CbGeAlD
Progesterone—Thrombophlebitis—Fluorouracil—head and neck cancer	0.000454	0.00513	CcSEcCtD
Progesterone—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000452	0.00511	CcSEcCtD
Progesterone—Swelling—Fluorouracil—head and neck cancer	0.000445	0.00503	CcSEcCtD
Progesterone—Amenorrhoea—Docetaxel—head and neck cancer	0.000445	0.00502	CcSEcCtD
Progesterone—Dysuria—Hydroxyurea—head and neck cancer	0.000441	0.00498	CcSEcCtD
Progesterone—SLC22A3—parotid gland—head and neck cancer	0.000441	0.0132	CbGeAlD
Progesterone—Disorientation—Fluorouracil—head and neck cancer	0.000439	0.00496	CcSEcCtD
Progesterone—Weight increased—Hydroxyurea—head and neck cancer	0.000429	0.00485	CcSEcCtD
Progesterone—SLC10A1—head—head and neck cancer	0.000427	0.0128	CbGeAlD
Progesterone—SIGMAR1—parotid gland—head and neck cancer	0.000426	0.0127	CbGeAlD
Progesterone—PGR—connective tissue—head and neck cancer	0.000424	0.0127	CbGeAlD
Progesterone—SLC22A3—saliva-secreting gland—head and neck cancer	0.000422	0.0126	CbGeAlD
Progesterone—Drug interaction—Docetaxel—head and neck cancer	0.000421	0.00476	CcSEcCtD
Progesterone—Drowsiness—Hydroxyurea—head and neck cancer	0.000421	0.00475	CcSEcCtD
Progesterone—Infestation NOS—Hydroxyurea—head and neck cancer	0.000421	0.00475	CcSEcCtD
Progesterone—Infestation—Hydroxyurea—head and neck cancer	0.000421	0.00475	CcSEcCtD
Progesterone—CYP17A1—thyroid gland—head and neck cancer	0.000419	0.0125	CbGeAlD
Progesterone—Haemoglobin—Vinblastine—head and neck cancer	0.000416	0.0047	CcSEcCtD
Progesterone—Haemorrhage—Vinblastine—head and neck cancer	0.000414	0.00468	CcSEcCtD
Progesterone—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000412	0.00466	CcSEcCtD
Progesterone—CYP1A1—mouth—head and neck cancer	0.000411	0.0123	CbGeAlD
Progesterone—Pharyngitis—Vinblastine—head and neck cancer	0.000411	0.00464	CcSEcCtD
Progesterone—Bone pain—Docetaxel—head and neck cancer	0.000408	0.00461	CcSEcCtD
Progesterone—SIGMAR1—saliva-secreting gland—head and neck cancer	0.000408	0.0122	CbGeAlD
Progesterone—PGR—epithelium—head and neck cancer	0.000402	0.012	CbGeAlD
Progesterone—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000398	0.00449	CcSEcCtD
Progesterone—Osteoarthritis—Fluorouracil—head and neck cancer	0.000393	0.00444	CcSEcCtD
Progesterone—Blood pressure increased—Docetaxel—head and neck cancer	0.000391	0.00441	CcSEcCtD
Progesterone—Hepatocellular injury—Docetaxel—head and neck cancer	0.000391	0.00441	CcSEcCtD
Progesterone—Pulmonary embolism—Docetaxel—head and neck cancer	0.000391	0.00441	CcSEcCtD
Progesterone—SLC22A3—connective tissue—head and neck cancer	0.000388	0.0116	CbGeAlD
Progesterone—NR3C2—trachea—head and neck cancer	0.000383	0.0114	CbGeAlD
Progesterone—Haemoglobin—Hydroxyurea—head and neck cancer	0.00038	0.00429	CcSEcCtD
Progesterone—Influenza like illness—Docetaxel—head and neck cancer	0.000379	0.00429	CcSEcCtD
Progesterone—Haemorrhage—Hydroxyurea—head and neck cancer	0.000378	0.00427	CcSEcCtD
Progesterone—OPRK1—head—head and neck cancer	0.000376	0.0112	CbGeAlD
Progesterone—Irritability—Fluorouracil—head and neck cancer	0.000375	0.00424	CcSEcCtD
Progesterone—CYP17A1—head—head and neck cancer	0.000372	0.0111	CbGeAlD
Progesterone—Fluid retention—Docetaxel—head and neck cancer	0.000371	0.00419	CcSEcCtD
Progesterone—Alopecia—Vinblastine—head and neck cancer	0.000366	0.00413	CcSEcCtD
Progesterone—ABCC1—parotid gland—head and neck cancer	0.000364	0.0109	CbGeAlD
Progesterone—CYP1B1—connective tissue—head and neck cancer	0.000356	0.0107	CbGeAlD
Progesterone—Neoplasm—Docetaxel—head and neck cancer	0.000353	0.00399	CcSEcCtD
Progesterone—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000351	0.00397	CcSEcCtD
Progesterone—Lightheadedness—Docetaxel—head and neck cancer	0.00035	0.00395	CcSEcCtD
Progesterone—Angiopathy—Hydroxyurea—head and neck cancer	0.000343	0.00387	CcSEcCtD
Progesterone—NR3C1—neck—head and neck cancer	0.000341	0.0102	CbGeAlD
Progesterone—Dysphagia—Fluorouracil—head and neck cancer	0.00034	0.00384	CcSEcCtD
Progesterone—AR—connective tissue—head and neck cancer	0.000337	0.0101	CbGeAlD
Progesterone—Ill-defined disorder—Vinblastine—head and neck cancer	0.000335	0.00378	CcSEcCtD
Progesterone—Alopecia—Hydroxyurea—head and neck cancer	0.000334	0.00377	CcSEcCtD
Progesterone—Anaemia—Vinblastine—head and neck cancer	0.000333	0.00376	CcSEcCtD
Progesterone—ESR1—connective tissue—head and neck cancer	0.000331	0.00991	CbGeAlD
Progesterone—Angina pectoris—Fluorouracil—head and neck cancer	0.000331	0.00374	CcSEcCtD
Progesterone—Erythema—Hydroxyurea—head and neck cancer	0.000329	0.00371	CcSEcCtD
Progesterone—Thrombophlebitis—Docetaxel—head and neck cancer	0.000328	0.0037	CcSEcCtD
Progesterone—Malaise—Vinblastine—head and neck cancer	0.000325	0.00367	CcSEcCtD
Progesterone—Vertigo—Vinblastine—head and neck cancer	0.000324	0.00366	CcSEcCtD
Progesterone—Swelling—Docetaxel—head and neck cancer	0.000322	0.00363	CcSEcCtD
Progesterone—AR—epithelium—head and neck cancer	0.00032	0.00959	CbGeAlD
Progesterone—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000316	0.00357	CcSEcCtD
Progesterone—Hepatic failure—Docetaxel—head and neck cancer	0.000316	0.00356	CcSEcCtD
Progesterone—SIGMAR1—trachea—head and neck cancer	0.000315	0.00941	CbGeAlD
Progesterone—ESR1—epithelium—head and neck cancer	0.000315	0.00941	CbGeAlD
Progesterone—Convulsion—Vinblastine—head and neck cancer	0.000312	0.00353	CcSEcCtD
Progesterone—SHBG—thyroid gland—head and neck cancer	0.000312	0.00934	CbGeAlD
Progesterone—Hypertension—Vinblastine—head and neck cancer	0.000311	0.00352	CcSEcCtD
Progesterone—PGR—lymphoid tissue—head and neck cancer	0.00031	0.00927	CbGeAlD
Progesterone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000305	0.00345	CcSEcCtD
Progesterone—Pneumonia—Fluorouracil—head and neck cancer	0.000305	0.00344	CcSEcCtD
Progesterone—Anaemia—Hydroxyurea—head and neck cancer	0.000304	0.00343	CcSEcCtD
Progesterone—Discomfort—Vinblastine—head and neck cancer	0.000303	0.00343	CcSEcCtD
Progesterone—Hot flush—Docetaxel—head and neck cancer	0.000303	0.00342	CcSEcCtD
Progesterone—Infestation NOS—Fluorouracil—head and neck cancer	0.000303	0.00342	CcSEcCtD
Progesterone—Infestation—Fluorouracil—head and neck cancer	0.000303	0.00342	CcSEcCtD
Progesterone—NR3C2—thyroid gland—head and neck cancer	0.000303	0.00905	CbGeAlD
Progesterone—Menopausal symptoms—Docetaxel—head and neck cancer	0.000301	0.0034	CcSEcCtD
Progesterone—Visual disturbance—Docetaxel—head and neck cancer	0.000299	0.00338	CcSEcCtD
Progesterone—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000297	0.00335	CcSEcCtD
Progesterone—Malaise—Hydroxyurea—head and neck cancer	0.000296	0.00335	CcSEcCtD
Progesterone—Urinary tract infection—Fluorouracil—head and neck cancer	0.000294	0.00332	CcSEcCtD
Progesterone—Conjunctivitis—Fluorouracil—head and neck cancer	0.000294	0.00332	CcSEcCtD
Progesterone—CYP1A1—parotid gland—head and neck cancer	0.000286	0.00856	CbGeAlD
Progesterone—Convulsion—Hydroxyurea—head and neck cancer	0.000285	0.00322	CcSEcCtD
Progesterone—Sinusitis—Fluorouracil—head and neck cancer	0.000284	0.00321	CcSEcCtD
Progesterone—Pain in extremity—Docetaxel—head and neck cancer	0.000284	0.0032	CcSEcCtD
Progesterone—PGR—thyroid gland—head and neck cancer	0.000281	0.00842	CbGeAlD
Progesterone—Anorexia—Vinblastine—head and neck cancer	0.00028	0.00317	CcSEcCtD
Progesterone—Migraine—Docetaxel—head and neck cancer	0.000279	0.00315	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000278	0.00314	CcSEcCtD
Progesterone—NR3C1—parotid gland—head and neck cancer	0.000278	0.00831	CbGeAlD
Progesterone—Discomfort—Hydroxyurea—head and neck cancer	0.000277	0.00312	CcSEcCtD
Progesterone—Haemoglobin—Fluorouracil—head and neck cancer	0.000273	0.00309	CcSEcCtD
Progesterone—Rhinitis—Fluorouracil—head and neck cancer	0.000273	0.00308	CcSEcCtD
Progesterone—Haemorrhage—Fluorouracil—head and neck cancer	0.000272	0.00307	CcSEcCtD
Progesterone—Pharyngitis—Fluorouracil—head and neck cancer	0.00027	0.00305	CcSEcCtD
Progesterone—ABCC1—trachea—head and neck cancer	0.000269	0.00805	CbGeAlD
Progesterone—NR3C2—head—head and neck cancer	0.000268	0.00803	CbGeAlD
Progesterone—Oedema—Hydroxyurea—head and neck cancer	0.000268	0.00303	CcSEcCtD
Progesterone—Infection—Hydroxyurea—head and neck cancer	0.000267	0.00301	CcSEcCtD
Progesterone—NR3C1—saliva-secreting gland—head and neck cancer	0.000266	0.00796	CbGeAlD
Progesterone—Paraesthesia—Vinblastine—head and neck cancer	0.000264	0.00298	CcSEcCtD
Progesterone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000263	0.00297	CcSEcCtD
Progesterone—Liver function test abnormal—Docetaxel—head and neck cancer	0.000262	0.00296	CcSEcCtD
Progesterone—Skin disorder—Hydroxyurea—head and neck cancer	0.000261	0.00294	CcSEcCtD
Progesterone—CYP1B1—lymphoid tissue—head and neck cancer	0.000261	0.0078	CbGeAlD
Progesterone—CYP17A1—lymph node—head and neck cancer	0.00026	0.00778	CbGeAlD
Progesterone—SLC22A3—thyroid gland—head and neck cancer	0.000257	0.0077	CbGeAlD
Progesterone—Breast disorder—Docetaxel—head and neck cancer	0.000256	0.0029	CcSEcCtD
Progesterone—Anorexia—Hydroxyurea—head and neck cancer	0.000256	0.00289	CcSEcCtD
Progesterone—Decreased appetite—Vinblastine—head and neck cancer	0.000256	0.00289	CcSEcCtD
Progesterone—Cramp muscle—Docetaxel—head and neck cancer	0.000255	0.00288	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000255	0.00288	CcSEcCtD
Progesterone—Nasopharyngitis—Docetaxel—head and neck cancer	0.000254	0.00286	CcSEcCtD
Progesterone—Constipation—Vinblastine—head and neck cancer	0.000252	0.00284	CcSEcCtD
Progesterone—Pain—Vinblastine—head and neck cancer	0.000252	0.00284	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00025	0.00283	CcSEcCtD
Progesterone—PGR—head—head and neck cancer	0.00025	0.00747	CbGeAlD
Progesterone—SIGMAR1—thyroid gland—head and neck cancer	0.000249	0.00745	CbGeAlD
Progesterone—AR—lymphoid tissue—head and neck cancer	0.000247	0.00738	CbGeAlD
Progesterone—Dysphagia—Docetaxel—head and neck cancer	0.000245	0.00277	CcSEcCtD
Progesterone—NR3C1—connective tissue—head and neck cancer	0.000244	0.00731	CbGeAlD
Progesterone—Feeling abnormal—Vinblastine—head and neck cancer	0.000242	0.00274	CcSEcCtD
Progesterone—ESR1—lymphoid tissue—head and neck cancer	0.000242	0.00725	CbGeAlD
Progesterone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000241	0.00272	CcSEcCtD
Progesterone—Alopecia—Fluorouracil—head and neck cancer	0.00024	0.00271	CcSEcCtD
Progesterone—Dyspnoea—Hydroxyurea—head and neck cancer	0.000239	0.0027	CcSEcCtD
Progesterone—CYP1A1—epithelium—head and neck cancer	0.000239	0.00716	CbGeAlD
Progesterone—SLC22A1—head—head and neck cancer	0.000239	0.00715	CbGeAlD
Progesterone—Angina pectoris—Docetaxel—head and neck cancer	0.000239	0.0027	CcSEcCtD
Progesterone—Somnolence—Hydroxyurea—head and neck cancer	0.000239	0.00269	CcSEcCtD
Progesterone—CYP1B1—thyroid gland—head and neck cancer	0.000237	0.00708	CbGeAlD
Progesterone—Erythema—Fluorouracil—head and neck cancer	0.000237	0.00267	CcSEcCtD
Progesterone—Dyspepsia—Hydroxyurea—head and neck cancer	0.000236	0.00267	CcSEcCtD
Progesterone—Decreased appetite—Hydroxyurea—head and neck cancer	0.000233	0.00263	CcSEcCtD
Progesterone—Abdominal pain—Vinblastine—head and neck cancer	0.000233	0.00263	CcSEcCtD
Progesterone—NR3C1—epithelium—head and neck cancer	0.000232	0.00694	CbGeAlD
Progesterone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000232	0.00262	CcSEcCtD
Progesterone—Fatigue—Hydroxyurea—head and neck cancer	0.000231	0.00261	CcSEcCtD
Progesterone—Pain—Hydroxyurea—head and neck cancer	0.000229	0.00259	CcSEcCtD
Progesterone—Constipation—Hydroxyurea—head and neck cancer	0.000229	0.00259	CcSEcCtD
Progesterone—SLC22A3—head—head and neck cancer	0.000228	0.00683	CbGeAlD
Progesterone—AR—thyroid gland—head and neck cancer	0.000224	0.00671	CbGeAlD
Progesterone—Weight increased—Docetaxel—head and neck cancer	0.000223	0.00252	CcSEcCtD
Progesterone—Vision blurred—Fluorouracil—head and neck cancer	0.000223	0.00252	CcSEcCtD
Progesterone—Weight decreased—Docetaxel—head and neck cancer	0.000222	0.00251	CcSEcCtD
Progesterone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000221	0.0025	CcSEcCtD
Progesterone—ESR1—thyroid gland—head and neck cancer	0.00022	0.00658	CbGeAlD
Progesterone—Pneumonia—Docetaxel—head and neck cancer	0.00022	0.00248	CcSEcCtD
Progesterone—Anaemia—Fluorouracil—head and neck cancer	0.000219	0.00247	CcSEcCtD
Progesterone—Infestation—Docetaxel—head and neck cancer	0.000219	0.00247	CcSEcCtD
Progesterone—Infestation NOS—Docetaxel—head and neck cancer	0.000219	0.00247	CcSEcCtD
Progesterone—Hypersensitivity—Vinblastine—head and neck cancer	0.000217	0.00245	CcSEcCtD
Progesterone—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000214	0.00242	CcSEcCtD
Progesterone—Jaundice—Docetaxel—head and neck cancer	0.000213	0.00241	CcSEcCtD
Progesterone—ABCC1—thyroid gland—head and neck cancer	0.000213	0.00637	CbGeAlD
Progesterone—Conjunctivitis—Docetaxel—head and neck cancer	0.000212	0.0024	CcSEcCtD
Progesterone—Body temperature increased—Hydroxyurea—head and neck cancer	0.000212	0.0024	CcSEcCtD
Progesterone—CYP1A1—trachea—head and neck cancer	0.000211	0.00633	CbGeAlD
Progesterone—Asthenia—Vinblastine—head and neck cancer	0.000211	0.00238	CcSEcCtD
Progesterone—CYP1B1—head—head and neck cancer	0.00021	0.00628	CbGeAlD
Progesterone—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000207	0.00233	CcSEcCtD
Progesterone—NR3C1—trachea—head and neck cancer	0.000205	0.00614	CbGeAlD
Progesterone—Convulsion—Fluorouracil—head and neck cancer	0.000205	0.00232	CcSEcCtD
Progesterone—Myalgia—Fluorouracil—head and neck cancer	0.000201	0.00228	CcSEcCtD
Progesterone—Chest pain—Fluorouracil—head and neck cancer	0.000201	0.00228	CcSEcCtD
Progesterone—Diarrhoea—Vinblastine—head and neck cancer	0.000201	0.00227	CcSEcCtD
Progesterone—Discomfort—Fluorouracil—head and neck cancer	0.000199	0.00225	CcSEcCtD
Progesterone—AR—head—head and neck cancer	0.000199	0.00595	CbGeAlD
Progesterone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000198	0.00223	CcSEcCtD
Progesterone—Haemoglobin—Docetaxel—head and neck cancer	0.000197	0.00223	CcSEcCtD
Progesterone—Rhinitis—Docetaxel—head and neck cancer	0.000197	0.00222	CcSEcCtD
Progesterone—Haemorrhage—Docetaxel—head and neck cancer	0.000196	0.00222	CcSEcCtD
Progesterone—Hepatitis—Docetaxel—head and neck cancer	0.000196	0.00222	CcSEcCtD
Progesterone—ESR1—head—head and neck cancer	0.000195	0.00584	CbGeAlD
Progesterone—Confusional state—Fluorouracil—head and neck cancer	0.000195	0.0022	CcSEcCtD
Progesterone—Pharyngitis—Docetaxel—head and neck cancer	0.000195	0.0022	CcSEcCtD
Progesterone—Dizziness—Vinblastine—head and neck cancer	0.000195	0.0022	CcSEcCtD
Progesterone—Urinary tract disorder—Docetaxel—head and neck cancer	0.000194	0.00219	CcSEcCtD
Progesterone—Oedema peripheral—Docetaxel—head and neck cancer	0.000193	0.00218	CcSEcCtD
Progesterone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000193	0.00218	CcSEcCtD
Progesterone—Oedema—Fluorouracil—head and neck cancer	0.000193	0.00218	CcSEcCtD
Progesterone—Connective tissue disorder—Docetaxel—head and neck cancer	0.000193	0.00218	CcSEcCtD
Progesterone—Asthenia—Hydroxyurea—head and neck cancer	0.000193	0.00217	CcSEcCtD
Progesterone—Urethral disorder—Docetaxel—head and neck cancer	0.000192	0.00217	CcSEcCtD
Progesterone—Infection—Fluorouracil—head and neck cancer	0.000192	0.00217	CcSEcCtD
Progesterone—Nervous system disorder—Fluorouracil—head and neck cancer	0.000189	0.00214	CcSEcCtD
Progesterone—Visual impairment—Docetaxel—head and neck cancer	0.000189	0.00214	CcSEcCtD
Progesterone—Tachycardia—Fluorouracil—head and neck cancer	0.000189	0.00213	CcSEcCtD
Progesterone—NR3C2—lymph node—head and neck cancer	0.000188	0.00562	CbGeAlD
Progesterone—Vomiting—Vinblastine—head and neck cancer	0.000187	0.00211	CcSEcCtD
Progesterone—Erythema multiforme—Docetaxel—head and neck cancer	0.000186	0.0021	CcSEcCtD
Progesterone—Headache—Vinblastine—head and neck cancer	0.000184	0.00208	CcSEcCtD
Progesterone—Anorexia—Fluorouracil—head and neck cancer	0.000184	0.00208	CcSEcCtD
Progesterone—Diarrhoea—Hydroxyurea—head and neck cancer	0.000184	0.00207	CcSEcCtD
Progesterone—Eye disorder—Docetaxel—head and neck cancer	0.000183	0.00207	CcSEcCtD
Progesterone—Cardiac disorder—Docetaxel—head and neck cancer	0.000182	0.00206	CcSEcCtD
Progesterone—Hypotension—Fluorouracil—head and neck cancer	0.00018	0.00204	CcSEcCtD
Progesterone—NR3C1—lymphoid tissue—head and neck cancer	0.000179	0.00535	CbGeAlD
Progesterone—Angiopathy—Docetaxel—head and neck cancer	0.000178	0.00201	CcSEcCtD
Progesterone—Dizziness—Hydroxyurea—head and neck cancer	0.000177	0.002	CcSEcCtD
Progesterone—Immune system disorder—Docetaxel—head and neck cancer	0.000177	0.002	CcSEcCtD
Progesterone—Mediastinal disorder—Docetaxel—head and neck cancer	0.000177	0.002	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000176	0.00199	CcSEcCtD
Progesterone—Nausea—Vinblastine—head and neck cancer	0.000175	0.00197	CcSEcCtD
Progesterone—PGR—lymph node—head and neck cancer	0.000175	0.00523	CbGeAlD
Progesterone—Insomnia—Fluorouracil—head and neck cancer	0.000175	0.00197	CcSEcCtD
Progesterone—Paraesthesia—Fluorouracil—head and neck cancer	0.000173	0.00196	CcSEcCtD
Progesterone—Alopecia—Docetaxel—head and neck cancer	0.000173	0.00196	CcSEcCtD
Progesterone—Dyspnoea—Fluorouracil—head and neck cancer	0.000172	0.00194	CcSEcCtD
Progesterone—Mental disorder—Docetaxel—head and neck cancer	0.000172	0.00194	CcSEcCtD
Progesterone—Somnolence—Fluorouracil—head and neck cancer	0.000172	0.00194	CcSEcCtD
Progesterone—Erythema—Docetaxel—head and neck cancer	0.000171	0.00193	CcSEcCtD
Progesterone—Malnutrition—Docetaxel—head and neck cancer	0.000171	0.00193	CcSEcCtD
Progesterone—Vomiting—Hydroxyurea—head and neck cancer	0.000171	0.00193	CcSEcCtD
Progesterone—Dyspepsia—Fluorouracil—head and neck cancer	0.00017	0.00192	CcSEcCtD
Progesterone—CYP1A2—thyroid gland—head and neck cancer	0.00017	0.00507	CbGeAlD
Progesterone—Rash—Hydroxyurea—head and neck cancer	0.000169	0.00191	CcSEcCtD
Progesterone—Dermatitis—Hydroxyurea—head and neck cancer	0.000169	0.00191	CcSEcCtD
Progesterone—Headache—Hydroxyurea—head and neck cancer	0.000168	0.0019	CcSEcCtD
Progesterone—Decreased appetite—Fluorouracil—head and neck cancer	0.000168	0.0019	CcSEcCtD
Progesterone—CYP1A1—thyroid gland—head and neck cancer	0.000167	0.00501	CbGeAlD
Progesterone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000167	0.00188	CcSEcCtD
Progesterone—Back pain—Docetaxel—head and neck cancer	0.000165	0.00187	CcSEcCtD
Progesterone—Pain—Fluorouracil—head and neck cancer	0.000165	0.00187	CcSEcCtD
Progesterone—Muscle spasms—Docetaxel—head and neck cancer	0.000164	0.00185	CcSEcCtD
Progesterone—NR3C1—thyroid gland—head and neck cancer	0.000162	0.00486	CbGeAlD
Progesterone—SLC22A3—lymph node—head and neck cancer	0.00016	0.00479	CbGeAlD
Progesterone—Nausea—Hydroxyurea—head and neck cancer	0.000159	0.0018	CcSEcCtD
Progesterone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000159	0.0018	CcSEcCtD
Progesterone—Anaemia—Docetaxel—head and neck cancer	0.000158	0.00178	CcSEcCtD
Progesterone—SIGMAR1—lymph node—head and neck cancer	0.000155	0.00463	CbGeAlD
Progesterone—Urticaria—Fluorouracil—head and neck cancer	0.000153	0.00173	CcSEcCtD
Progesterone—Syncope—Docetaxel—head and neck cancer	0.000153	0.00173	CcSEcCtD
Progesterone—Body temperature increased—Fluorouracil—head and neck cancer	0.000153	0.00172	CcSEcCtD
Progesterone—Palpitations—Docetaxel—head and neck cancer	0.000151	0.0017	CcSEcCtD
Progesterone—Loss of consciousness—Docetaxel—head and neck cancer	0.00015	0.0017	CcSEcCtD
Progesterone—Cough—Docetaxel—head and neck cancer	0.000149	0.00168	CcSEcCtD
Progesterone—CYP1A1—head—head and neck cancer	0.000148	0.00444	CbGeAlD
Progesterone—Convulsion—Docetaxel—head and neck cancer	0.000148	0.00167	CcSEcCtD
Progesterone—Hypertension—Docetaxel—head and neck cancer	0.000147	0.00167	CcSEcCtD
Progesterone—CYP1B1—lymph node—head and neck cancer	0.000147	0.0044	CbGeAlD
Progesterone—Arthralgia—Docetaxel—head and neck cancer	0.000145	0.00164	CcSEcCtD
Progesterone—Myalgia—Docetaxel—head and neck cancer	0.000145	0.00164	CcSEcCtD
Progesterone—Chest pain—Docetaxel—head and neck cancer	0.000145	0.00164	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000144	0.00163	CcSEcCtD
Progesterone—NR3C1—head—head and neck cancer	0.000144	0.00431	CbGeAlD
Progesterone—Hypersensitivity—Fluorouracil—head and neck cancer	0.000142	0.00161	CcSEcCtD
Progesterone—Dry mouth—Docetaxel—head and neck cancer	0.000142	0.00161	CcSEcCtD
Progesterone—Confusional state—Docetaxel—head and neck cancer	0.000141	0.00159	CcSEcCtD
Progesterone—Anaphylactic shock—Docetaxel—head and neck cancer	0.000139	0.00157	CcSEcCtD
Progesterone—Oedema—Docetaxel—head and neck cancer	0.000139	0.00157	CcSEcCtD
Progesterone—AR—lymph node—head and neck cancer	0.000139	0.00417	CbGeAlD
Progesterone—Infection—Docetaxel—head and neck cancer	0.000138	0.00156	CcSEcCtD
Progesterone—Shock—Docetaxel—head and neck cancer	0.000137	0.00155	CcSEcCtD
Progesterone—Nervous system disorder—Docetaxel—head and neck cancer	0.000137	0.00154	CcSEcCtD
Progesterone—ESR1—lymph node—head and neck cancer	0.000137	0.00409	CbGeAlD
Progesterone—Pruritus—Fluorouracil—head and neck cancer	0.000137	0.00154	CcSEcCtD
Progesterone—Tachycardia—Docetaxel—head and neck cancer	0.000136	0.00154	CcSEcCtD
Progesterone—Skin disorder—Docetaxel—head and neck cancer	0.000135	0.00153	CcSEcCtD
Progesterone—Anorexia—Docetaxel—head and neck cancer	0.000133	0.0015	CcSEcCtD
Progesterone—ABCC1—lymph node—head and neck cancer	0.000132	0.00396	CbGeAlD
Progesterone—Diarrhoea—Fluorouracil—head and neck cancer	0.000132	0.00149	CcSEcCtD
Progesterone—Hypotension—Docetaxel—head and neck cancer	0.00013	0.00147	CcSEcCtD
Progesterone—Dizziness—Fluorouracil—head and neck cancer	0.000128	0.00144	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000127	0.00143	CcSEcCtD
Progesterone—Insomnia—Docetaxel—head and neck cancer	0.000126	0.00142	CcSEcCtD
Progesterone—Paraesthesia—Docetaxel—head and neck cancer	0.000125	0.00141	CcSEcCtD
Progesterone—Dyspnoea—Docetaxel—head and neck cancer	0.000124	0.0014	CcSEcCtD
Progesterone—ABCB1—epithelium—head and neck cancer	0.000124	0.00372	CbGeAlD
Progesterone—Somnolence—Docetaxel—head and neck cancer	0.000124	0.0014	CcSEcCtD
Progesterone—Vomiting—Fluorouracil—head and neck cancer	0.000123	0.00139	CcSEcCtD
Progesterone—Dyspepsia—Docetaxel—head and neck cancer	0.000123	0.00139	CcSEcCtD
Progesterone—Rash—Fluorouracil—head and neck cancer	0.000122	0.00138	CcSEcCtD
Progesterone—Dermatitis—Fluorouracil—head and neck cancer	0.000122	0.00137	CcSEcCtD
Progesterone—Decreased appetite—Docetaxel—head and neck cancer	0.000121	0.00137	CcSEcCtD
Progesterone—Headache—Fluorouracil—head and neck cancer	0.000121	0.00137	CcSEcCtD
Progesterone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00012	0.00136	CcSEcCtD
Progesterone—Fatigue—Docetaxel—head and neck cancer	0.00012	0.00136	CcSEcCtD
Progesterone—Constipation—Docetaxel—head and neck cancer	0.000119	0.00135	CcSEcCtD
Progesterone—Pain—Docetaxel—head and neck cancer	0.000119	0.00135	CcSEcCtD
Progesterone—Feeling abnormal—Docetaxel—head and neck cancer	0.000115	0.0013	CcSEcCtD
Progesterone—Nausea—Fluorouracil—head and neck cancer	0.000115	0.0013	CcSEcCtD
Progesterone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000114	0.00129	CcSEcCtD
Progesterone—Body temperature increased—Docetaxel—head and neck cancer	0.00011	0.00124	CcSEcCtD
Progesterone—Abdominal pain—Docetaxel—head and neck cancer	0.00011	0.00124	CcSEcCtD
Progesterone—ABCB1—trachea—head and neck cancer	0.00011	0.00329	CbGeAlD
Progesterone—CYP2D6—head—head and neck cancer	0.000107	0.00321	CbGeAlD
Progesterone—CYP1A1—lymph node—head and neck cancer	0.000104	0.00311	CbGeAlD
Progesterone—Hypersensitivity—Docetaxel—head and neck cancer	0.000103	0.00116	CcSEcCtD
Progesterone—NR3C1—lymph node—head and neck cancer	0.000101	0.00302	CbGeAlD
Progesterone—Asthenia—Docetaxel—head and neck cancer	0.0001	0.00113	CcSEcCtD
Progesterone—Pruritus—Docetaxel—head and neck cancer	9.86e-05	0.00111	CcSEcCtD
Progesterone—ABCB1—lymphoid tissue—head and neck cancer	9.57e-05	0.00286	CbGeAlD
Progesterone—Diarrhoea—Docetaxel—head and neck cancer	9.54e-05	0.00108	CcSEcCtD
Progesterone—Dizziness—Docetaxel—head and neck cancer	9.22e-05	0.00104	CcSEcCtD
Progesterone—Vomiting—Docetaxel—head and neck cancer	8.86e-05	0.001	CcSEcCtD
Progesterone—Rash—Docetaxel—head and neck cancer	8.79e-05	0.000993	CcSEcCtD
Progesterone—Dermatitis—Docetaxel—head and neck cancer	8.78e-05	0.000992	CcSEcCtD
Progesterone—Headache—Docetaxel—head and neck cancer	8.73e-05	0.000986	CcSEcCtD
Progesterone—ABCB1—thyroid gland—head and neck cancer	8.69e-05	0.0026	CbGeAlD
Progesterone—Nausea—Docetaxel—head and neck cancer	8.28e-05	0.000935	CcSEcCtD
Progesterone—ABCB1—head—head and neck cancer	7.71e-05	0.00231	CbGeAlD
Progesterone—ABCB1—lymph node—head and neck cancer	5.4e-05	0.00162	CbGeAlD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.43e-05	0.000203	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.43e-05	0.000203	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—TYMS—head and neck cancer	1.42e-05	0.000201	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—YAP1—head and neck cancer	1.41e-05	0.000199	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—GSTM1—head and neck cancer	1.4e-05	0.000199	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—NAT2—head and neck cancer	1.38e-05	0.000196	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—TYMS—head and neck cancer	1.37e-05	0.000194	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—IL2—head and neck cancer	1.37e-05	0.000194	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NOTCH1—head and neck cancer	1.36e-05	0.000193	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—DPYD—head and neck cancer	1.36e-05	0.000193	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—GSTM1—head and neck cancer	1.35e-05	0.000192	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—NAT2—head and neck cancer	1.35e-05	0.000191	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—GPX1—head and neck cancer	1.34e-05	0.00019	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.34e-05	0.00019	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.33e-05	0.000188	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.33e-05	0.000188	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTGS2—head and neck cancer	1.31e-05	0.000186	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—GPX1—head and neck cancer	1.3e-05	0.000184	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—YAP1—head and neck cancer	1.29e-05	0.000183	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CYP1A1—head and neck cancer	1.28e-05	0.000182	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—AKT1—head and neck cancer	1.28e-05	0.000182	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—NAT2—head and neck cancer	1.27e-05	0.00018	CbGpPWpGaD
Progesterone—ABCC1—Disease—NOTCH1—head and neck cancer	1.27e-05	0.00018	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—NAT2—head and neck cancer	1.26e-05	0.000179	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL2—head and neck cancer	1.24e-05	0.000176	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.24e-05	0.000176	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—TYMS—head and neck cancer	1.24e-05	0.000175	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—TYMS—head and neck cancer	1.23e-05	0.000175	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—NOTCH1—head and neck cancer	1.23e-05	0.000175	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.22e-05	0.000173	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GSTM1—head and neck cancer	1.22e-05	0.000173	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—DPYD—head and neck cancer	1.21e-05	0.000172	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—NOTCH1—head and neck cancer	1.21e-05	0.000172	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.2e-05	0.000171	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—DPYD—head and neck cancer	1.18e-05	0.000168	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GPX1—head and neck cancer	1.17e-05	0.000166	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GPX1—head and neck cancer	1.17e-05	0.000166	CbGpPWpGaD
Progesterone—PGR—Gene Expression—MAPK3—head and neck cancer	1.16e-05	0.000164	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CYP1A1—head and neck cancer	1.16e-05	0.000164	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CYP1A1—head and neck cancer	1.16e-05	0.000164	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—YAP1—head and neck cancer	1.15e-05	0.000163	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—TYMS—head and neck cancer	1.15e-05	0.000163	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.14e-05	0.000162	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTEN—head and neck cancer	1.14e-05	0.000162	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GSTM1—head and neck cancer	1.14e-05	0.000161	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—TYMS—head and neck cancer	1.13e-05	0.000161	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.13e-05	0.000161	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—YAP1—head and neck cancer	1.12e-05	0.000159	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GSTM1—head and neck cancer	1.12e-05	0.000159	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—DPYD—head and neck cancer	1.11e-05	0.000158	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—DPYD—head and neck cancer	1.11e-05	0.000157	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PIK3CA—head and neck cancer	1.1e-05	0.000156	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTGS2—head and neck cancer	1.1e-05	0.000156	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.09e-05	0.000155	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GPX1—head and neck cancer	1.09e-05	0.000154	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CYP1A1—head and neck cancer	1.08e-05	0.000153	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NAT2—head and neck cancer	1.08e-05	0.000153	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GPX1—head and neck cancer	1.07e-05	0.000152	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NOTCH1—head and neck cancer	1.07e-05	0.000151	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CYP1A1—head and neck cancer	1.06e-05	0.000151	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—YAP1—head and neck cancer	1.06e-05	0.00015	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.06e-05	0.00015	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.06e-05	0.00015	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTGS2—head and neck cancer	1.05e-05	0.000149	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—YAP1—head and neck cancer	1.05e-05	0.000149	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.02e-05	0.000144	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—MAPK3—head and neck cancer	9.99e-06	0.000142	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.68e-06	0.000137	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTEN—head and neck cancer	9.56e-06	0.000136	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—MAPK1—head and neck cancer	9.51e-06	0.000135	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—EGFR—head and neck cancer	9.51e-06	0.000135	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—DPYD—head and neck cancer	9.45e-06	0.000134	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTGS2—head and neck cancer	9.43e-06	0.000134	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL2—head and neck cancer	9.38e-06	0.000133	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.21e-06	0.000131	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTEN—head and neck cancer	9.17e-06	0.00013	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCND1—head and neck cancer	9.14e-06	0.00013	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—PIK3CA—head and neck cancer	9.09e-06	0.000129	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—AKT1—head and neck cancer	8.96e-06	0.000127	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—YAP1—head and neck cancer	8.96e-06	0.000127	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—TYMS—head and neck cancer	8.93e-06	0.000127	CbGpPWpGaD
Progesterone—AR—Gene Expression—MAPK3—head and neck cancer	8.83e-06	0.000125	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GSTM1—head and neck cancer	8.83e-06	0.000125	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTEN—head and neck cancer	8.82e-06	0.000125	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.64e-06	0.000123	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GPX1—head and neck cancer	8.46e-06	0.00012	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.45e-06	0.00012	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—TYMS—head and neck cancer	8.44e-06	0.00012	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CYP1A1—head and neck cancer	8.37e-06	0.000119	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GSTM1—head and neck cancer	8.34e-06	0.000118	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NAT2—head and neck cancer	8.31e-06	0.000118	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PIK3CA—head and neck cancer	8.25e-06	0.000117	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTEN—head and neck cancer	8.22e-06	0.000117	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PIK3CA—head and neck cancer	8.05e-06	0.000114	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	8e-06	0.000113	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GPX1—head and neck cancer	7.99e-06	0.000113	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—head and neck cancer	7.97e-06	0.000113	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—head and neck cancer	7.9e-06	0.000112	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—STAT3—head and neck cancer	7.89e-06	0.000112	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.88e-06	0.000112	CbGpPWpGaD
Progesterone—PGR—Gene Expression—AKT1—head and neck cancer	7.82e-06	0.000111	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—TYMS—head and neck cancer	7.74e-06	0.00011	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTM1—head and neck cancer	7.65e-06	0.000109	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—head and neck cancer	7.64e-06	0.000108	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—head and neck cancer	7.64e-06	0.000108	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MAPK3—head and neck cancer	7.54e-06	0.000107	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.54e-06	0.000107	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—head and neck cancer	7.42e-06	0.000105	CbGpPWpGaD
Progesterone—ABCC1—Disease—STAT3—head and neck cancer	7.36e-06	0.000104	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL2—head and neck cancer	7.34e-06	0.000104	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GPX1—head and neck cancer	7.33e-06	0.000104	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—DPYD—head and neck cancer	7.29e-06	0.000103	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP1A1—head and neck cancer	7.25e-06	0.000103	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MAPK1—head and neck cancer	7.17e-06	0.000102	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—head and neck cancer	7.17e-06	0.000102	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—head and neck cancer	7.16e-06	0.000102	CbGpPWpGaD
Progesterone—ABCC1—Disease—MAPK3—head and neck cancer	7.03e-06	9.97e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—YAP1—head and neck cancer	6.92e-06	9.81e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTEN—head and neck cancer	6.91e-06	9.8e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—TYMS—head and neck cancer	6.91e-06	9.8e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—head and neck cancer	6.89e-06	9.77e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTEN—head and neck cancer	6.89e-06	9.77e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—head and neck cancer	6.88e-06	9.76e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.87e-06	9.75e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTM1—head and neck cancer	6.83e-06	9.69e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MAPK3—head and neck cancer	6.81e-06	9.65e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—head and neck cancer	6.75e-06	9.57e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TYMS—head and neck cancer	6.74e-06	9.57e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—head and neck cancer	6.74e-06	9.56e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.73e-06	9.55e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MAPK3—head and neck cancer	6.7e-06	9.51e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MAPK1—head and neck cancer	6.69e-06	9.49e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—head and neck cancer	6.68e-06	9.48e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTM1—head and neck cancer	6.66e-06	9.45e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—head and neck cancer	6.66e-06	9.45e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—head and neck cancer	6.58e-06	9.34e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GPX1—head and neck cancer	6.54e-06	9.28e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.5e-06	9.22e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP1A1—head and neck cancer	6.47e-06	9.18e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—head and neck cancer	6.47e-06	9.18e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—head and neck cancer	6.41e-06	9.09e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GPX1—head and neck cancer	6.38e-06	9.05e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TYMS—head and neck cancer	6.35e-06	9.01e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP1A1—head and neck cancer	6.32e-06	8.96e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—head and neck cancer	6.31e-06	8.96e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TYMS—head and neck cancer	6.3e-06	8.94e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTM1—head and neck cancer	6.28e-06	8.91e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—head and neck cancer	6.24e-06	8.85e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTM1—head and neck cancer	6.23e-06	8.83e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—head and neck cancer	6.22e-06	8.83e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—head and neck cancer	6.18e-06	8.77e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—head and neck cancer	6.02e-06	8.54e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GPX1—head and neck cancer	6.01e-06	8.53e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—head and neck cancer	6.01e-06	8.52e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—head and neck cancer	6e-06	8.51e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GPX1—head and neck cancer	5.96e-06	8.46e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—head and neck cancer	5.96e-06	8.45e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.96e-06	8.45e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	5.95e-06	8.45e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK3—head and neck cancer	5.9e-06	8.38e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP1A1—head and neck cancer	5.9e-06	8.37e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.87e-06	8.33e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—head and neck cancer	5.8e-06	8.23e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—head and neck cancer	5.76e-06	8.17e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK1—head and neck cancer	5.62e-06	7.97e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—head and neck cancer	5.62e-06	7.97e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—head and neck cancer	5.59e-06	7.93e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—head and neck cancer	5.51e-06	7.82e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—head and neck cancer	5.51e-06	7.81e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—head and neck cancer	5.5e-06	7.81e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TYMS—head and neck cancer	5.38e-06	7.64e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—head and neck cancer	5.37e-06	7.62e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—head and neck cancer	5.37e-06	7.61e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTM1—head and neck cancer	5.32e-06	7.55e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.32e-06	7.54e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—head and neck cancer	5.28e-06	7.5e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—head and neck cancer	5.18e-06	7.35e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GPX1—head and neck cancer	5.09e-06	7.23e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—head and neck cancer	5.08e-06	7.21e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP1A1—head and neck cancer	5.04e-06	7.16e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—head and neck cancer	4.98e-06	7.06e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—head and neck cancer	4.87e-06	6.92e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—head and neck cancer	4.86e-06	6.89e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.85e-06	6.88e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—head and neck cancer	4.74e-06	6.72e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—head and neck cancer	4.72e-06	6.69e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—head and neck cancer	4.7e-06	6.67e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—head and neck cancer	4.7e-06	6.67e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—head and neck cancer	4.68e-06	6.64e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—head and neck cancer	4.63e-06	6.57e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—head and neck cancer	4.59e-06	6.51e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—head and neck cancer	4.52e-06	6.41e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—head and neck cancer	4.51e-06	6.4e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK3—head and neck cancer	4.42e-06	6.28e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—head and neck cancer	4.34e-06	6.16e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—head and neck cancer	4.31e-06	6.12e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—head and neck cancer	4.24e-06	6.01e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—head and neck cancer	4.23e-06	6e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK1—head and neck cancer	4.21e-06	5.97e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—head and neck cancer	4.21e-06	5.97e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TYMS—head and neck cancer	4.15e-06	5.89e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.14e-06	5.88e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.11e-06	5.83e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—head and neck cancer	4.1e-06	5.82e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—head and neck cancer	3.98e-06	5.65e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—head and neck cancer	3.97e-06	5.63e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—head and neck cancer	3.94e-06	5.6e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GPX1—head and neck cancer	3.93e-06	5.58e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.89e-06	5.52e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—head and neck cancer	3.88e-06	5.51e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—head and neck cancer	3.85e-06	5.46e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—head and neck cancer	3.84e-06	5.45e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—head and neck cancer	3.76e-06	5.34e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—head and neck cancer	3.76e-06	5.33e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	3.65e-06	5.18e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—head and neck cancer	3.54e-06	5.02e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—head and neck cancer	3.53e-06	5.01e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.51e-06	4.98e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—head and neck cancer	3.46e-06	4.91e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—head and neck cancer	3.46e-06	4.9e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—head and neck cancer	3.38e-06	4.79e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—head and neck cancer	3.36e-06	4.76e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—head and neck cancer	3.28e-06	4.65e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—head and neck cancer	3.22e-06	4.57e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—head and neck cancer	3.17e-06	4.5e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—head and neck cancer	3.09e-06	4.38e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—head and neck cancer	3.06e-06	4.35e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—head and neck cancer	3.06e-06	4.34e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—head and neck cancer	3e-06	4.26e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—head and neck cancer	2.98e-06	4.23e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—head and neck cancer	2.89e-06	4.11e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.65e-06	3.76e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—head and neck cancer	2.62e-06	3.71e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—head and neck cancer	2.5e-06	3.55e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.37e-06	3.36e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—head and neck cancer	2.36e-06	3.35e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.31e-06	3.28e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.31e-06	3.28e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	2.18e-06	3.09e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—head and neck cancer	2.17e-06	3.08e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—head and neck cancer	2.16e-06	3.06e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—head and neck cancer	2.02e-06	2.86e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—head and neck cancer	1.93e-06	2.74e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—head and neck cancer	1.89e-06	2.68e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.85e-06	2.62e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—head and neck cancer	1.78e-06	2.52e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—head and neck cancer	1.76e-06	2.5e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—head and neck cancer	1.51e-06	2.14e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.42e-06	2.02e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—head and neck cancer	1.16e-06	1.65e-05	CbGpPWpGaD
